The Science, Policy, and Potential of Cell and Gene Therapies

Wednesday, December 4, 2019

12:00 p.m. – 12:10 p.m. Welcome and Introductions

Sarah J. Dash, MPH

President and Chief Executive Officer, Alliance for Health Policy, @AllHealthPolicy

Jocelyn Ulrich, MPH

Deputy Vice President of Policy and Research, Pharmaceutical Research and Manufacturers of America, @PhRMA

12:10 p.m. – 12:50 p.m. Panelist Opening Remarks

Gillian Woollett, D.Phil., M.A.

Principal Research Scientist, Avalere Health, @avalerehealth

Joanne Kurtzberg, M.D.

Director, Marcus Center for Cellular Cures (MC3), Duke University School of Medicine

John Glasspool

Senior Advisor, MIT Center for Biomedical Innovation: NEWDIGS, Financing and Reimbursement of Cures in the US (FoCUS) Project

Rena Conti, Ph.D.

Associate Research Director, Biopharma and Public Policy, Institute for Health System Innovation and Policy, Boston University, @contirena1

12:50 p.m. – 1:30 p.m. Question and Answer Session

Jun24

past webinar

COVID-19 Webinar Series Session 20 - Tensions, Tradeoffs, and Takeaways: What’s at Stake for America 100 Days into the Pandemic  and Where We Go From Here

Just over 100 days have passed since the COVID-19 pandemic was declared a national emergency on March 13, 2020. The pandemic has led to sweeping ramifications throughout the American economy and society as a whole. During this interactive discussion, three preeminent health policy leaders examined the lessons learned three months into the crisis and lay out considerations for decision-makers as they work to stem the tide of the pandemic and build a more resilient health care system.

Learn More

Share